These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 32168782)
1. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells. Erdős E; Bálint BL Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782 [TBL] [Abstract][Full Text] [Related]
2. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function. Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232 [TBL] [Abstract][Full Text] [Related]
3. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression. Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376 [TBL] [Abstract][Full Text] [Related]
4. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Kong SL; Li G; Loh SL; Sung WK; Liu ET Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914 [TBL] [Abstract][Full Text] [Related]
5. COUP-TFII is a modulator of cell-type-specific genetic programs based on genomic localization maps. Erdős E; Bálint BL J Biotechnol; 2019 Aug; 301():11-17. PubMed ID: 31158411 [TBL] [Abstract][Full Text] [Related]
6. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896 [TBL] [Abstract][Full Text] [Related]
7. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas. Droog M; Nevedomskaya E; Kim Y; Severson T; Flach KD; Opdam M; Schuurman K; Gradowska P; Hauptmann M; Dackus G; Hollema H; Mourits M; Nederlof P; van Boven H; Linn SC; Wessels L; van Leeuwen FE; Zwart W Cancer Res; 2016 Jul; 76(13):3773-84. PubMed ID: 27197147 [TBL] [Abstract][Full Text] [Related]
8. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network. Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382 [No Abstract] [Full Text] [Related]
9. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover. Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297 [TBL] [Abstract][Full Text] [Related]
10. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells. Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394 [TBL] [Abstract][Full Text] [Related]
11. Genomic Characterization of Endothelial Enhancers Reveals a Multifunctional Role for NR2F2 in Regulation of Arteriovenous Gene Expression. Sissaoui S; Yu J; Yan A; Li R; Yukselen O; Kucukural A; Zhu LJ; Lawson ND Circ Res; 2020 Mar; 126(7):875-888. PubMed ID: 32065070 [TBL] [Abstract][Full Text] [Related]
12. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3. Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341 [TBL] [Abstract][Full Text] [Related]
13. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance. Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579 [TBL] [Abstract][Full Text] [Related]
14. Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance. Jehanno C; Fernandez-Calero T; Habauzit D; Avner S; Percevault F; Jullion E; Le Goff P; Coissieux MM; Muenst S; Marin M; Michel D; Métivier R; Flouriot G Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194507. PubMed ID: 32113984 [TBL] [Abstract][Full Text] [Related]
15. Unique ERalpha cistromes control cell type-specific gene regulation. Krum SA; Miranda-Carboni GA; Lupien M; Eeckhoute J; Carroll JS; Brown M Mol Endocrinol; 2008 Nov; 22(11):2393-406. PubMed ID: 18818283 [TBL] [Abstract][Full Text] [Related]
16. Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet. McCune K; Bhat-Nakshatri P; Thorat MA; Nephew KP; Badve S; Nakshatri H Cancer Res; 2010 Jan; 70(2):685-96. PubMed ID: 20068169 [TBL] [Abstract][Full Text] [Related]
17. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis. Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101 [TBL] [Abstract][Full Text] [Related]
18. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells. Lee JY; Park YJ; Oh N; Kwack KB; Park KS Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748 [TBL] [Abstract][Full Text] [Related]
19. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade. Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6. Yamaguchi N; Nakayama Y; Yamaguchi N J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]